Rchr
J-GLOBAL ID：201901008738699862   Update date: Jan. 29, 2024

Murakoshi Maki

Murakoshi Maki
Affiliation and department：
Juntendo University Faculty of Medicine

About Juntendo University Faculty of Medicine


Job title： Associate Professor
Research field  (3)： Internal medicine - General ,  Metabolism and endocrinology ,  Nephrology
Papers (62)：
  • Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki. Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. International journal of molecular sciences. 2024. 25. 2
  • Maki Murakoshi, Nozomu Kamei, Yusuke Suzuki, Mitsunobu Kubota, Michiyoshi Sanuki, Hirotaka Tashiro, Takumi Iwasawa, Kazunori Kato, Marenao Tanaka, Masato Furuhashi, et al. Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: an observational cohort study. Diabetes Research and Clinical Practice. 2023. 111017-111017
  • Maki Murakoshi, Takashi Kobayashi, Masao Kihara, Seiji Ueda, Yusuke Suzuki, Tomohito Gohda. The proteinuria-lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease. Nephrology (Carlton, Vic.). 2023. 28. 10. 540-547
  • Maki Murakoshi, Takumi Iwasawa, Takeo Koshida, Yusuke Suzuki, Tomohito Gohda, Kazunori Kato. Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction. Diagnostics (Basel, Switzerland). 2022. 12. 12
  • Tomohito Gohda, Maki Murakoshi. Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials. International journal of molecular sciences. 2022. 23. 22
ｍore...
MISC (65)：
  • 村越 真紀, 岩澤 卓弥, 合田 朋仁, 鈴木 祐介, 加藤 和則. 慢性腎臓病患者における血中EphA2濃度と尿蛋白量、推算糸球体濾過量との関連性. 日本腎臓学会誌. 2022. 64. 3. 277-277
  • 作間 宏子, 村越 真紀, 合田 朋仁, 鈴木 祐介. 1型糖尿病マウスにおけるSGLT2阻害薬治療が腎・肝のPGRN発現に及ぼす影響. 日本腎臓学会誌. 2022. 64. 3. 286-286
  • 越田 剛生, 合田 朋仁, 村越 真紀, 石坂 匡則, 山城 雄一郎, 鈴木 祐介. 糖尿病の有無に応じた慢性腎臓病患者における腸内細菌叢の解析. 日本腎臓学会誌. 2022. 64. 3. 289-289
  • 越田 剛生, 合田 朋仁, 村越 真紀, 鈴木 祐介, 山城 雄一郎. 血液透析患者における腸内細菌叢の解析. 日本透析医学会雑誌. 2022. 55. Suppl.1. 482-482
  • 合田 朋仁, 村越 真紀, 上田 誠二, 木村 健二郎, 細谷 龍男, 鈴木 祐介. 高尿酸血症合併CKD患者においてフェブキソスタット(XOi)が血中TNF受容体(sTNFR)濃度に及ぼす影響. 日本腎臓学会誌. 2021. 63. 4. 428-428
ｍore...
Professional career (1)：
  • Ph.D in Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM